Phase I clinical study of AZD2171, an oral vascular endothelial growth factor signaling inhibitor, in patients with advanced solid tumors (Q43430750)
Jump to navigation
Jump to search
scientific article published in July 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I clinical study of AZD2171, an oral vascular endothelial growth factor signaling inhibitor, in patients with advanced solid tumors |
scientific article published in July 2007 |
Statements
1 reference
Phase I clinical study of AZD2171, an oral vascular endothelial growth factor signaling inhibitor, in patients with advanced solid tumors (English)
1 reference
Joachim Drevs
1 reference
Patrizia Siegert
1 reference
Michael Medinger
1 reference
Klaus Mross
1 reference
Ralph Strecker
1 reference
Ute Zirrgiebel
1 reference
Jan Harder
1 reference
Hubert Blum
1 reference
Jane Robertson
1 reference
Juliane M Jürgensmeier
1 reference
Thomas A Puchalski
1 reference
Helen Young
1 reference
Owain Saunders
1 reference
Clemens Unger
1 reference
1 July 2007
1 reference
1 reference
Identifiers
1 reference